ロード中...
Emerging treatments for postmenopausal osteoporosis – focus on denosumab
The pathway of the receptor activator of the nuclear factor κB ligand (RANKL), RANK and osteoprotegerin (OPG) plays a central role in coupling bone formation and resorption during normal bone turnover and in a wide spectrum of diseases characterized by disturbed bone remodeling, increased bone resor...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2697589/ https://ncbi.nlm.nih.gov/pubmed/19554095 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|